Drug Shortage Report for MYLAN-EFAVIRENZ/EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE

Last updated on 2019-06-19 History
Report ID 47356
Drug Identification Number 02461412
Brand name MYLAN-EFAVIRENZ/EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE
Common or Proper name EFAVIRENZ/EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE
Company Name MYLAN PHARMACEUTICALS ULC
Active Ingredient(s) EFAVIRENZ TENOFOVIR DISOPROXIL FUMARATE EMTRICITABINE
Strength(s) 600MG 300MG 200MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 30 BT
ATC code J05AR
ATC description DIRECT ACTING ANTIVIRALS
Reason for shortage Delay in shipping of the drug.
Anticipated start date 2019-06-11
Actual start date
Estimated end date 2019-06-21
Actual end date 2019-06-18
Shortage status Resolved
Updated date 2019-06-19
Company comments
Health Canada comments
Contact Address 85 ADVANCE ROAD
ETOBICOKE, ONTARIO
CANADA M8Z 2S6
Company contact information Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v1 2018-04-27 English Compare
v2 2018-04-27 French Compare
v3 2018-04-28 English Compare
v4 2018-06-05 English Compare
v5 2018-06-05 French Compare
v6 2018-06-25 English Compare
v7 2018-06-25 English Compare
v8 2018-06-25 English Compare
v9 2018-06-25 English Compare
v10 2018-08-21 English Compare
v11 2018-08-21 French Compare
v12 2018-08-27 English Compare
v13 2018-08-27 French Compare
v14 2018-09-10 English Compare
v15 2018-09-10 French Compare
v16 2018-09-24 English Compare
v17 2018-09-24 French Compare
v18 2018-10-17 English Compare
v19 2018-10-17 French Compare
v20 2018-10-23 English Compare

Showing 1 to 20 of 64